Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis

被引:51
作者
Aleksza, M
Irinyi, B
Lukács, A
Antal-Szalmás, P
Hunyadi, J
Szegedi, A
机构
[1] Univ Debrecen, Med & Hlth Sci Ctr, Dept Dermatol, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Internal Med 3, H-4012 Debrecen, Hungary
[3] Univ Debrecen, Med & Hlth Sci Ctr, Dept Clin Biochem & Mol Pathol, H-4012 Debrecen, Hungary
关键词
atopic dermatitis; CD4+cells; CD8+cells; flow cytometry; interleukin-4; interleukin-13;
D O I
10.1046/j.1365-2133.2002.05013.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background A number of studies exist demonstrating the increased expression of type 2 cytokines and decreased capacity to produce interferon-gamma (IFN-gamma) in peripheral blood mononuclear cells (PBMCs) of patients with atopic dermatitis (AD). Objectives To clarify the results of recent studies concerning the role of interleukin (IL)-4 and IL-13 in PBMCs of AD patients, we analysed the activation status of lymphocyte subpopulations. Methods We measured the intracellular expression and serum levels of certain type 1 and type 2 cytokines, using cell surface and intracellular cytokine staining, flow cytometry and enzyme-linked immunosorbent assay techniques. Results The frequency of IL-10 and IL-13 producing CD4+ and CD8+ T cells was significantly higher in patients with AD, while the frequency of IFN-gamma secreting helper and cytotoxic T cells was significantly lower in patients with AD than in control subjects. The serum levels of IL-10 and IL-13 were also significantly increased. There were no significant differences observed between the experimental groups in the frequency of IL-4 producing CD4+ and CD8+ cells. Conclusions This study demonstrates a type 2 cytokine production in the CD4+ and CD8+ T cells of AD patients, which is characterized by an elevated IL-13, but not by IL-4 secretion, and by an increased level of the immunoregulatory IL-10, which can contribute to a decrease in IFN-gamma expression.
引用
收藏
页码:1135 / 1141
页数:7
相关论文
共 44 条
  • [1] Akdis M, 1997, J IMMUNOL, V159, P4611
  • [2] Akdis M, 1999, J IMMUNOL, V163, P466
  • [3] BRAATHEN LR, 1985, ACTA DERM-VENEREOL, P133
  • [4] ACTIVATED MAST-CELLS PRODUCE INTERLEUKIN-13
    BURD, PR
    THOMPSON, WC
    MAX, EE
    MILLS, FC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) : 1373 - 1380
  • [5] DEL PG, 1993, J IMMUNOL, V150, P353
  • [6] IMMUNOREGULATORY PROPERTIES OF IL-13 - ITS POTENTIAL ROLE IN ATOPIC DISEASE
    DEVRIES, JE
    ZURAWSKI, G
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 106 (03) : 175 - 179
  • [7] *EUR TASK FORC AT, 1993, DERMATOLOGY, V198, P23
  • [8] A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
    Grewe, M
    Bruijnzeel-Koomen, CAFM
    Schöpf, E
    Thepen, T
    Langeveld-Wildschut, AG
    Ruzicka, T
    Krutmann, J
    [J]. IMMUNOLOGY TODAY, 1998, 19 (08): : 359 - 361
  • [9] In vivo expression of IL-12 and IL-13 in atopic dermatitis
    Hamid, Q
    Naseer, T
    Minshall, EW
    Song, YL
    Boguniewicz, M
    Leung, DYM
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (01) : 225 - 231
  • [10] DIFFERENTIAL IN-SITU CYTOKINE GENE-EXPRESSION IN ACUTE VERSUS CHRONIC ATONIC DERMATITIS
    HAMID, Q
    BOGUNIEWICZ, M
    LEUNG, DYM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) : 870 - 876